116 related articles for article (PubMed ID: 11587209)
1. The class II tumor-suppressor gene RARRES3 is expressed in B cell lymphocytic leukemias and down-regulated with disease progression.
Casanova B; de la Fuente MT; Garcia-Gila M; Sanz L; Silva A; Garcia-Marco JA; Garcia-Pardo A
Leukemia; 2001 Oct; 15(10):1521-6. PubMed ID: 11587209
[TBL] [Abstract][Full Text] [Related]
2. Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion.
Joshi AD; Dickinson JD; Hegde GV; Sanger WG; Armitage JO; Bierman PJ; Bociek RG; Devetten MP; Vose JM; Joshi SS
Cancer Genet Cytogenet; 2007 Jan; 172(2):120-6. PubMed ID: 17213020
[TBL] [Abstract][Full Text] [Related]
3. Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia.
Liu Y; Corcoran M; Rasool O; Ivanova G; Ibbotson R; Grandér D; Iyengar A; Baranova A; Kashuba V; Merup M; Wu X; Gardiner A; Mullenbach R; Poltaraus A; Hultström AL; Juliusson G; Chapman R; Tiller M; Cotter F; Gahrton G; Yankovsky N; Zabarovsky E; Einhorn S; Oscier D
Oncogene; 1997 Nov; 15(20):2463-73. PubMed ID: 9395242
[TBL] [Abstract][Full Text] [Related]
4. Translocation t(X;11)(q13;q23) in B-cell chronic lymphocytic leukemia disrupts two novel genes.
Kalla C; Nentwich H; Schlotter M; Mertens D; Wildenberger K; Döhner H; Stilgenbauer S; Lichter P
Genes Chromosomes Cancer; 2005 Feb; 42(2):128-43. PubMed ID: 15543602
[TBL] [Abstract][Full Text] [Related]
5. The class II tumour suppressor gene RARRES3 maps to 11q12, not 11q23.
Auer RL; Bertoni F; Jones C; Cotter FE
Leukemia; 2002 Jul; 16(7):1396; author reply 1396-7. PubMed ID: 12094268
[No Abstract] [Full Text] [Related]
6. Alterations of cyclin-dependent kinase 4 inhibitor (p16INK4A/MTS1) gene structure and expression in acute lymphoblastic leukemias.
Delmer A; Tang R; Senamaud-Beaufort C; Paterlini P; Brechot C; Zittoun R
Leukemia; 1995 Jul; 9(7):1240-5. PubMed ID: 7630199
[TBL] [Abstract][Full Text] [Related]
7. Deletions at 11q23 in different lymphoma subtypes.
Zhu Y; Monni O; Franssila K; Elonen E; Vilpo J; Joensuu H; Knuutila S
Haematologica; 2000 Sep; 85(9):908-12. PubMed ID: 10980627
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
[TBL] [Abstract][Full Text] [Related]
9. Decreased or altered expression of the FHIT gene in human leukemias.
Sugimoto K; Yamada K; Miyagawa K; Hirai H; Oshimi K
Stem Cells; 1997; 15(3):223-8. PubMed ID: 9170214
[TBL] [Abstract][Full Text] [Related]
10. Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion.
Aalto Y; El-Rifa W; Vilpo L; Ollila J; Nagy B; Vihinen M; Vilpo J; Knuutila S
Leukemia; 2001 Nov; 15(11):1721-8. PubMed ID: 11681413
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia.
Mertens D; Wolf S; Schroeter P; Schaffner C; Döhner H; Stilgenbauer S; Lichter P
Blood; 2002 Jun; 99(11):4116-21. PubMed ID: 12010815
[TBL] [Abstract][Full Text] [Related]
12. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
[TBL] [Abstract][Full Text] [Related]
13. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
Stilgenbauer S; Nickolenko J; Wilhelm J; Wolf S; Weitz S; Döhner K; Boehm T; Döhner H; Lichter P
Oncogene; 1998 Apr; 16(14):1891-7. PubMed ID: 9583687
[TBL] [Abstract][Full Text] [Related]
14. New insights into the pathogenesis of chronic lymphocytic leukemia.
Klein U; Dalla-Favera R
Semin Cancer Biol; 2010 Dec; 20(6):377-83. PubMed ID: 21029776
[TBL] [Abstract][Full Text] [Related]
15. Exclusion of Leu1 and Leu2 genes as tumor suppressor genes in 13q14.3-deleted B-CLL.
Rondeau G; Moreau I; Bézieau S; Cadoret E; Moisan JP; Devilder MC
Leukemia; 1999 Oct; 13(10):1630-2. PubMed ID: 10516767
[TBL] [Abstract][Full Text] [Related]
16. Analysis of 11q22-q23 deletion target genes in B-cell chronic lymphocytic leukaemia: evidence for a pathogenic role of NPAT, CUL5, and PPP2R1B.
Kalla C; Scheuermann MO; Kube I; Schlotter M; Mertens D; Döhner H; Stilgenbauer S; Lichter P
Eur J Cancer; 2007 May; 43(8):1328-35. PubMed ID: 17449237
[TBL] [Abstract][Full Text] [Related]
17. Expression of gene encoding P65 oncofetal protein in acute and chronic leukemias.
Balcerczak E; Bartkowiak J; Błoński JZ; Robak T; Mirowski M
Neoplasma; 2002; 49(5):295-9. PubMed ID: 12458326
[TBL] [Abstract][Full Text] [Related]
18. 11q22.3 deletion in B-chronic lymphocytic leukemia is specifically associated with bulky lymphadenopathy and ZAP-70 expression but not reduced expression of adhesion/cell surface receptor molecules.
Dickinson JD; Gilmore J; Iqbal J; Sanger W; Lynch JC; Chan J; Bierman PJ; Joshi SS
Leuk Lymphoma; 2006 Feb; 47(2):231-44. PubMed ID: 16321852
[TBL] [Abstract][Full Text] [Related]
19. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
Kienle DL; Korz C; Hosch B; Benner A; Mertens D; Habermann A; Kröber A; Jäger U; Lichter P; Döhner H; Stilgenbauer S
J Clin Oncol; 2005 Jun; 23(16):3780-92. PubMed ID: 15867199
[TBL] [Abstract][Full Text] [Related]
20. Unique gene expression and clinical characteristics are associated with the 11q23 deletion in chronic lymphocytic leukaemia.
Dickinson JD; Smith LM; Sanger WG; Zhou G; Townley P; Lynch JC; Pavletic ZS; Bierman PJ; Joshi SS
Br J Haematol; 2005 Feb; 128(4):460-71. PubMed ID: 15686453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
